THACI, D.; MENTER, A.; WU, J. J.; ARIKAN, D.; KUPPER, H.; BERESWILL, M.; VALDECANTOS, W. C. Long-Term Safety and Effectiveness of Adalimumab for Moderat-to-Severe Psoriasis: Results from the Eight-Year Interim Analysis of the ESPIRIT Registry. SKIN The Journal of Cutaneous Medicine, v. 1, n. 3.1, p. s22, 27 Oct. 2017.